FDA Alert – Artificial Tears

On Feb. 3, the US Food and Drug Administration (FDA) issued a warning statement to consumers and health care practitioners to not purchase and to immediately stop using EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears, due to potential bacterial contamination. Both products have been voluntarily recalled.

The Centers for Disease Control (CDC) has developed related resources for health care providers:

- - Sample Customizable Patient Notification Letter
  - Provider Talking Points about Artificial Tears

The CDC continues to investigate the multistate outbreak of an extensively drug-resistant strain of Pseudomonas aeruginosa associated with artificial tears.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Six reasons OMIC is the best choice for ophthalmologists in America.

Expertise unmatched.

OMIC's sole mission is to serve ophthalmology. The premier source of ophthalmic claims data and loss prevention materials, OMIC's member hotline is the most used ophthalmic consultative service of its kind and OMIC.com is the most visited web site in America for ophthalmic risk management advice and patient consent documents.

Policyholder Services

FDA Alert – Artificial Tears